Need professional-grade analysis? Visit stockanalysis.com
$12.31M
0.06
27
N/A
Predilife (ALPRE) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at EUR3.10, down 0.32% from the previous close.
Over the past year, ALPRE has traded between a low of EUR2.96 and a high of EUR4.29. The stock has lost 12.2% over this period. It is currently 27.7% below its 52-week high.
Predilife has a market capitalization of $12.31M, with a price-to-earnings ratio of 0.06.
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer prediction test based on the patient's individual risk; and DenSeeMammo, a breast density measurement software. Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Side-by-side comparison against top Healthcare peers.